latest articles

MN Cos. Affected as J&J Exits Stent Market

As Johnson & Johnson prepares to stop manufacturing drug-coated stents, competitors like Medtronic and Boston Scientific could see a boost in sales. Surmodics, however, a supplier to Johnson & Johnson, said that it is "disappointed" with the news.

MN Med-Tech Cos. Dispute New Heart Device Study

Roughly 40 percent of patients implanted with cardiac resynchronization therapy devices may not reap benefits from the expensive treatment, according to a new study. But med-tech giants Medtronic and St. Jude disagree, stating that current guidelines for using the devices were established through credible clinical trials.

Best Buy Sidesteps U.K. Rumors

The electronics retailer reported a decline in first-quarter earnings but outperformed analysts' expectations, sending its stock price up on Tuesday morning. And the company said that it doesn't comment on rumors like one that suggested that it may postpone its expansion plans in Europe.